# Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure

> **NCT07692932** · NA · NOT_YET_RECRUITING · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 100 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **OTHER:** blood drawn

## Key facts

- **NCT ID:** NCT07692932
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692932, "Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*